Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, Katalin, Buckstein, Michael, Ni, Houping, Weissman, Drew·2005·Immunity
DOI 10.1016/j.immuni.2005.06.008

Cited by (1,004)

Items 301–400 of 1,004

  1. RNA epigenetics
    Nian Liu, Tao Pan · 2014 · Translational research
  2. Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
    Farah Yasmin, Hala Najeeb, Unaiza Naeem, Abdul Moeed, Abdul Raafe Atif, Muhammad Sohaib Asghar, Nayef Nimri, Maryam Saleem, Dhrubajyoti Bandyopadhyay, Chayakrit Krittanawong et al. · 2023 · Immunity Inflammation and Disease
  3. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity
    Tsai, Shang Jui, Atai, Nadia A., Cacciottolo, Mafalda, Nice, Justin, Salehi, Arjang, Guo, Chenxu, Sedgwick, Alanna, Kanagavelu, Saravana, Gould, Stephen J. · 2021 · Journal of Biological Chemistry
  4. Induction of type I interferon by RNA viruses: cellular receptors and their substrates
    Alina Baum, Adolfo García‐Sastre · 2009 · Amino Acids
  5. Analysis of RNA modifications by liquid chromatography–tandem mass spectrometry
    Kathrin L. Thüring, Katharina Schmid, Patrick Keller, Mark Helm · 2016 · Methods
  6. Engineered tRNAs suppress nonsense mutations in cells and in vivo
    Suki Albers, Elizabeth C. Allen, Nikhil Bharti, Marcos Davyt, Disha Joshi, Carlos G. Pérez‐García, Leonardo A. Santos, Rajesh Mukthavaram, Miguel Angel Delgado-Toscano, Brandon Molina et al. · 2023 · Nature
  7. Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety
    Van der Jeught, Kevin, De Koker, Stefaan, Bialkowski, Lukasz, Heirman, Carlo, Tjok Joe, Patrick, Perche, Federico, Maenhout, Sarah, Bevers, Sanne, Broos, Katrijn, Deswarte, Kim et al. · 2018 · ACS Nano
  8. In vivo chimeric antigen receptor (CAR)-T cell therapy
    Adrian Bot, Andrew M. Scharenberg, Kevin M. Friedman, Lin T. Guey, Robert Hofmeister, James I. Andorko, Michael Klichinsky, Frank Neumann, Jagesh V. Shah, Andrew J. Swayer et al. · 2025 · Nature Reviews Drug Discovery
  9. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization
    Jérôme Denis, Nathalie Majeau, Elizabeth Acosta‐Ramírez, Christian Savard, Marie-Claude Bédard, Sabrina Simard, Katia Lecours, Marilène Bolduc, Christine Paré, Bernard E Willems et al. · 2007 · Virology
  10. Role of RNA methyltransferases in tissue renewal and pathology
    Sandra Blanco, Michaela Frye · 2014 · Current Opinion in Cell Biology
  11. Synthetic Polymers for Drug, Gene, and Vaccine Delivery
    Yajun Xu, Jie Chen, Jianxun Ding, Jing Sun, Wantong Song, Zhaohui Tang, Chunsheng Xiao, Xuesi Chen · 2025 · Polymer science & technology.
  12. Nanomedicine-Based Approaches for mRNA Delivery
    Uchida, Satoshi, Perche, Federico, Pichon, Chantal, Cabral, Horacio · 2020 · Molecular Pharmaceutics
  13. Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner
    Subba Rao Nallagatla, Philip C. Bevilacqua · 2008 · RNA
  14. Synthesis of low immunogenicity RNA with high-temperature in vitro transcription
    Monica Z. Wu, Haruichi Asahara, George Tzertzinis, Bijoyita Roy · 2020 · RNA
  15. Immunogenicity of In Vitro -Transcribed RNA
    Xin Ni Mu, Sun Hur · 2021 · Accounts of Chemical Research
  16. Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
    Jisun Lee, Matthew Charles Woodruff, Eui Ho Kim, Jae‐Hwan Nam · 2023 · Experimental & Molecular Medicine
  17. RNA‐based medicine: from molecular mechanisms to therapy
    Anke Sparmann, Jörg Vogel · 2023 · The EMBO Journal
  18. Challenges and advances towards the rational design of mRNA vaccines
    Charlotte Pollard, Stefaan De Koker, Xavier Saelens, Guido L. Vanham, Johan Grooten · 2013 · Trends in Molecular Medicine
  19. Nanomaterials for Therapeutic RNA Delivery
    Xuexiang Han, Michael J. Mitchell, Guangjun Nie · 2020 · Matter
  20. Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid‐like nanoparticles resolves liver fibrosis
    Carolina Jiménez Calvente, Alfica Sehgal, Yury V. Popov, Yong Ook Kim, Victor F. Zevallos, Uğur Şahin, Mustafa Diken, Detlef Schuppan · 2015 · Hepatology
  21. Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
    Rossella Sartorius, Maria Trovato, Roberta Manco, Luciana D’Apice, Piergiuseppe De Berardinis · 2021 · npj Vaccines
  22. The evolution of immune mechanisms
    Nadia Danilova · 2006 · Journal of Experimental Zoology Part B Molecular and Developmental Evolution
  23. Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
    Jessica Foster, Namrata Choudhari, Jessica Perazzelli, Julie Storm, Ted J. Hofmann, Payal Jain, Phillip B. Storm, Norbert Pardi, Drew Weissman, Angela Jae Waanders et al. · 2018 · Human Gene Therapy
  24. Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: restoring the immunogenicity of immunosilent mRNA
    Verbeke, Rein, Lentacker, Ine, Wayteck, Laura, Breckpot, Karine, Van Bockstal, Mieke, Descamps, Benedicte, Vanhove, Christian, De Smedt, Stefaan C., Dewitte, Heleen · 2017 · Journal of Controlled Release
  25. Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines
    Ger T. Rijkers, Nynke Weterings, Andrés Obregón‐Henao, Tara Dutt, Taru S. Dutt, Frans J. van Overveld, Marcela I. Henao-Tamayo · 2021 · Vaccines
  26. Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery
    Mingdi Hu, Xiaoyan Li, Zhen You, Rong Cai, Chunying Chen · 2023 · Advanced Materials
  27. In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle
    Satoshi Uchida, Keiji Itaka, Hirokuni Uchida, Kentaro Hayakawa, Toru Ogata, Takehiko Ishii, Shigeto Fukushima, Kensuke Osada, Kazunori Kataoka · 2013 · PLoS ONE
  28. Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics
    Kai K. Ewert, Pablo Scodeller, Lorena Simón‐Gracia, Victoria M. Steffes, Emily A. Wonder, Tambet Teesalu, Cyrus R. Safinya · 2021 · Pharmaceutics
  29. The immunostimulatory nature of mRNA lipid nanoparticles
    Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, Dor Breier, Dan Peer · 2024 · Advanced Drug Delivery Reviews
  30. Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review
    Francesco Nappi · 2024 · International Journal of Molecular Sciences
  31. Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life
    Trepotec, Zeljka, Geiger, Johannes, Plank, Christian, Aneja, Manish K., Rudolph, Carsten · 2019 · RNA
  32. Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.
    Katalin Karikó, Drew Weissman · 2007 · PubMed
  33. Toll-like receptor signaling controls reactivation of KSHV from latency
    Sean M. Gregory, John A. West, Patrick Dillon, Chelsey Hilscher, Dirk P. Dittmer, Blossom Damania · 2009 · Proceedings of the National Academy of Sciences
  34. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles
    Ying-Chuck Kou, Lina Shao, Hsiu‐Huei Peng, Rebecca Rosetta, Daniela del Gaudio, Andrew F. Wagner, Tarek Khalaf Al-Hussaini, Ignatia B. Van den Veyver · 2007 · Molecular Human Reproduction
  35. mRNA as novel technology for passive immunotherapy
    Thomas Schlake, Andreas Theß, Moritz Thran, Ingo Jordan · 2018 · Cellular and Molecular Life Sciences
  36. Recognition of viral single-stranded RNA by Toll-like receptors☆
    Sandra S. Diebold · 2008 · Advanced Drug Delivery Reviews
  37. Nucleoside modified mRNA vaccines for infectious diseases
    Pardi, Norbert, Weissman, Drew · 2017 · Methods in molecular biology
  38. Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies
    Pu-Sheng Wei, Nagasri Thota, Greshma John, Evelyn Chang, Sunjae Lee, Yuanjun Wang, Zitao Ma, Yu-Hsuan Tsai, Kuo‐Ching Mei · 2024 · Journal of Controlled Release
  39. Nucleoside modifications in the regulation of gene expression: focus on tRNA
    Markus Duechler, Grażyna Leszczyńska, Elżbieta Sochacka, Barbara Nawrot · 2016 · Cellular and Molecular Life Sciences
  40. Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery
    Grayson Tilstra, Julien Couture‐Senécal, Yan Ming Anson Lau, Alanna M. Manning, D. Wong, Wanda W. Janaeska, Titobioluwa A. Wuraola, Janice Pang, Omar F. Khan · 2023 · Journal of the American Chemical Society
  41. Semi-quantitative detection of pseudouridine modifications and type I/II hypermodifications in human mRNAs using direct long-read sequencing
    Sepideh Tavakoli, Mohammad Nabizadeh, Amr K. Makhamreh, Howard Gamper, Caroline A. McCormick, Neda Kari Rezapour, Ya‐Ming Hou, Meni Wanunu, Sara H. Rouhanifard · 2023 · Nature Communications
  42. Mapping and significance of the mRNA methylome
    Tennille Sibbritt, Hardip R. Patel, Thomas Preiß · 2013 · Wiley Interdisciplinary Reviews - RNA
  43. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
    Kenji Yamato, Taketo Yamada, Masahiro Kizaki, Kumiko Ui‐Tei, Yukikazu Natori, Masato Fujino, Tatsuji Nishihara, Y Ikeda, Yasutomo Nasu, Kaoru Saigo et al. · 2007 · Cancer Gene Therapy
  44. Identification of modifications in microbial, native tRNA that suppress immunostimulatory activity
    Stefanie M. Gehrig, Mariel-Esther Eberle, Flavia Botschen, Katharina Rimbach, Florian Eberle, Tatjana Eigenbrod, Steffen Kaiser, W. Michael Holmes, Volker A. Erdmann, Mathias Sprinzl et al. · 2012 · The Journal of Experimental Medicine
  45. VEGF amplifies transcription through ETS1 acetylation to enable angiogenesis
    Jiahuan Chen, Yi Fu, Daniel S. Day, Ye Sun, Shiyan Wang, Xiaodong Liang, Fei Gu, Fang Zhang, Sean M. Stevens, Pingzhu Zhou et al. · 2017 · Nature Communications
  46. Current Status of Zika Virus Vaccines: Successes and Challenges
    Aryamav Pattnaik, Bikash Ranjan Sahoo, Asit K. Pattnaik · 2020 · Vaccines
  47. Clinical delivery of circular RNA: Lessons learned from RNA drug development
    Tiana L. Young, Kevin Chang Wang, Andrew Varley, Bowen Li · 2023 · Advanced Drug Delivery Reviews
  48. Branched chemically modified poly(A) tails enhance the translation capacity of mRNA
    Hongyu Chen, Dangliang Liu, Jianting Guo, Abhishek J. Aditham, Yiming Zhou, Jiakun Tian, Shuchen Luo, Jingyi Ren, Alvin Hsu, Jiahao Huang et al. · 2024 · Nature Biotechnology
  49. Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection
    Andrew Vaillant · 2016 · Antiviral Research
  50. m6A RNA Methylation in Cardiovascular Diseases
    Siyi Wu, Shuchen Zhang, Xiaoguang Wu, Xiang Zhou · 2020 · Molecular Therapy
  51. Development and Delivery Systems of mRNA Vaccines
    Yongjun Liang, Liping Huang, Tiancai Liu · 2021 · Frontiers in Bioengineering and Biotechnology
  52. Structural and Functional Analyses of the Human Toll-like Receptor 3
    Jingchuan Sun, Karen E. Duffy, C. T. Ranjith-Kumar, Jin Xiong, Roberta J. Lamb, Jon Santos, M. Hema, Mark Cunningham, Andreas Holzenburg, Robert T. Sarisky et al. · 2006 · Journal of Biological Chemistry
  53. Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
    Cindy Patinote, Nour Bou Karroum, Georges Moarbess, Natalina Cirnat, Issam Kassab, Pierre‐Antoine Bonnet, Carine Deleuze‐Masquéfa · 2020 · European Journal of Medicinal Chemistry
  54. mRNA-Based Vaccines
    Frank Kowalzik, Daniel Schreiner, Christian Jensen, Daniel Teschner, Stephan Gehring, Fred Zepp · 2021 · Vaccines
  55. Guanosine and its modified derivatives are endogenous ligands for TLR7
    Takuma Shibata, Umeharu Ohto, Shosaku� Nomura, Kayoko Kibata, Yuji Motoi, Yan Zhang, Yusuke Murakami, Ryutaro Fukui, Tatsushi Ishimoto, Shigetoshi Sano et al. · 2015 · International Immunology
  56. Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon
    Broos, Katrijn, Van der Jeught, Kevin, Puttemans, Janik, Goyvaerts, Cleo, Heirman, Carlo, Dewitte, Heleen, Verbeke, Rein, Lentacker, Ine, Thielemans, Kris, Breckpot, Karine · 2016 · Molecular Therapy — Nucleic Acids
  57. N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1
    Kun Yang, Ryan B. Huang, Haruhiko Fujihira, Tadashi Suzuki, Nan Yan · 2018 · The Journal of Experimental Medicine
  58. mRNA therapeutics deliver a hopeful message
    Zifu Zhong, Séan Mc Cafferty, Francis Combes, Hanne Huysmans, Joyca De Temmerman, Arlieke Gitsels, Daisy C.G. Vanrompay, João Portela Catani, Niek N. Sanders · 2018 · Nano Today
  59. The 2′- O -methylation status of a single guanosine controls transfer RNA–mediated Toll-like receptor 7 activation or inhibition
    Stefanie Jöckel, Gernot Nees, Romy Sommer, Yang Zhao, Dmitry Cherkasov, Hiroyuki Hori, Gundi Ehm, Markus Schnare, Marianne Nain, Andreas Martin Kaufmann et al. · 2012 · The Journal of Experimental Medicine
  60. A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
    Karl‐Josef Kallen, Andreas Theß · 2013 · Therapeutic Advances in Vaccines
  61. RNA Modifications Modulate Activation of Innate Toll-Like Receptors
    Isabel Freund, Tatjana Eigenbrod, Mark Helm, Alexander H. Dalpke · 2019 · Genes
  62. Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
    Sita Awasthi, Lauren M. Hook, Norbert Pardi, Fushan Wang, Arpita Myles, Michael P. Cancro, Gary H. Cohen, Drew Weissman, Harvey M. Friedman · 2019 · Science Immunology
  63. Tumor vaccination using messenger RNA: prospects of a future therapy
    Sebastian Kreiter, Mustafa Diken, Abderraouf Selmi, Özlem Türeci, Uğur Şahin · 2011 · Current Opinion in Immunology
  64. N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications
    Jia‐Hui Luo, Tao Xu, Kai Sun · 2021 · Frontiers in Cell and Developmental Biology
  65. Small‐interfering RNA s ( siRNA s) as a promising tool for ocular therapy
    Ana Guzmán‐Aránguez, Patricia Loma, Jesús J. Pintor · 2013 · British Journal of Pharmacology
  66. Identification and analysis of the N6-methyladenosine in the Saccharomyces cerevisiae transcriptome
    Wei Chen, Hong T. Tran, Zhi-Yong Liang, Hao Lin, Liqing Zhang · 2015 · Scientific Reports
  67. Vaccine adjuvants: Tailoring innate recognition to send the right message
    Ed C. Lavelle, Craig P. McEntee · 2024 · Immunity
  68. Development of mRNA Vaccines: Scientific and Regulatory Issues
    Knezevic, Ivana, Liu, Margaret A., Peden, Keith, Zhou, Tiequn, Kang, Hye-Na · 2021 · Vaccines
  69. From structural design to delivery: mRNA therapeutics for cancer immunotherapy
    Feng Zhou, Lujia Huang, Shiqin Li, Wenfang Yang, Fangmin Chen, Zhixiong Cai, Xiaolong Liu, Wujun Xu, Vesa‐Pekka Lehto, Ulrich Lächelt et al. · 2023 · Exploration
  70. Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
    Trepotec, Zeljka, Lichtenegger, Eva, Plank, Christian, Aneja, Manish K., Rudolph, Carsten · 2019 · Molecular Therapy
  71. Chemically modified RNA activated matrices enhance bone regeneration
    Satheesh Elangovan, Behnoush Khorsand, Anh‐Vu Do, Liu Hong, Alexander Dewerth, Michael Kormann, Ryan D. Ross, Dale Rick Sumner, Chantal Allamargot, Aliasger K. Salem · 2015 · Journal of Controlled Release
  72. Nucleic acids and endosomal pattern recognition: how to tell friend from foe?
    Eva Brencicova, Sandra S. Diebold · 2013 · Frontiers in Cellular and Infection Microbiology
  73. The complementarity of DDR, nucleic acids and anti-tumour immunity
    Anand V. R. Kornepati, Cody M. Rogers, Patrick Sung, Tyler Jay Curiel · 2023 · Nature
  74. Regulation of autoreactive B cell responses to endogenous TLR ligands
    Avalos, Ana Maria, Busconi, Liliana, Marshak-Rothstein, Ann · 2010 · Autoimmunity
  75. RNA Mediated toll-like receptor stimulation in health and disease
    Dalpke, Alexander H., Helm, Mark · 2012 · RNA Biology
  76. mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
    Mariona Estapé Sentí, Lucía García del Valle, Raymond Michel Schiffelers · 2024 · Advanced Drug Delivery Reviews
  77. RNA interference and innate immunity.
    M. Sioud · 2007 · Advanced Drug Delivery Reviews
  78. Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.
    Devoldere, Joke, Dewitte, Heleen, De Smedt, Stefaan C., Remaut, Katrien · 2016 · Drug Discovery Today
  79. SARS-CoV Regulates Immune Function-Related Gene Expression in Human Monocytic Cells
    Wan‐Chung Hu, Yu-Ting Yen, Sher Singh, Chuan‐Liang Kao, Betty A. Wu‐Hsieh · 2012 · Viral Immunology
  80. Optimizing Cardiac Delivery of Modified mRNA
    Nishat Sultana, Ajit Magadum, Yoav Hadas, Jason Kondrat, Neha Singh, Elias Youssef, Damelys Calderon, Elena Chepurko, Nicole C. Dubois, Roger J. Hajjar et al. · 2017 · Molecular Therapy
  81. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach
    Ishtiaque Ahammad, Samia Sultana Lira · 2020 · International Journal of Biological Macromolecules
  82. The role of N6-methyladenosine mRNA in the tumor microenvironment
    Min Li, Xuan Zha, Shengjun Wang · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  83. Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
    Javier Tadeo Granados-Riveron, Guillermo Aquino‐Jarquín · 2021 · Biomedicine & Pharmacotherapy
  84. Making innate sense of mRNA vaccine adjuvanticity
    Kouji Kobiyama, Ken J. Ishii · 2022 · Nature Immunology
  85. Cellular Dynamics of RNA Modification
    Chengqi Yi, Tao Pan · 2011 · Accounts of Chemical Research
  86. Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy
    Youn, Hyewon, Chung, June-Key · 2015 · Expert Opinion on Biological Therapy
  87. Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo
    Yizhou Dong, J. Robert Dorkin, Weiheng Wang, Philip Chang, Matthew J. Webber, Benjamin C. Tang, Junghoon Yang, Inbal Abutbul Ionita, Dganit Danino, Frank DeRosa et al. · 2016 · Nano Letters
  88. mRNA-encoded, constitutively active STINGV155M is a potent genetic adjuvant of antigen-specific CD8+ T cell response
    Sze‐Wah Tse, Kristine M. McKinney, William Walker, Mychael Nguyen, Jared Iacovelli, Clayton G. Small, Kristen Hopson, Tal Z. Zaks, Eric Huang · 2021 · Molecular Therapy
  89. Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety
    Vlatkovic, Irena · 2021 · Biomedicines
  90. mRNA: Fulfilling the Promise of Gene Therapy
    Drew Weissman, Katalin Karikó · 2015 · Molecular Therapy
  91. Future considerations for the mRNA-lipid nanoparticle vaccine platform
    Botond Z. Igyártó, Sonya Jacobsen, Sonia Ndeupen · 2021 · Current Opinion in Virology
  92. Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy
    Heya Lin, Wei Guo Xiong, Lili Fu, Jie Yi, Jiantang Yang · 2025 · Molecular Biomedicine
  93. Accessing the therapeutic potential of immunostimulatory nucleic acids
    Winfried Barchet, Vera Wimmenauer, Martin Schlee, Gunther Hartmann · 2008 · Current Opinion in Immunology
  94. Current landscape of mRNA technologies and delivery systems for new modality therapeutics
    Ruei‐Min Lu, Hsiang-En Hsu, Ser John Lynon P. Perez, Monika Kumari, Guanhong Chen, Ming-Hsiang Hong, Yin-Shiou Lin, Ching-Hang Liu, Shih-Han Ko, Christian Angelo P. Concio et al. · 2024 · Journal of Biomedical Science
  95. An overview of rational design of mRNA-based therapeutics and vaccines
    To, Kenneth K.W., Cho, William C.S. · 2021 · Expert Opinion on Drug Discovery
  96. RNA modification in cardiovascular disease: implications for therapeutic interventions
    Cong Wang, Xuyang Hou, Qing Guan, Huiling Zhou, Zhou Li, Lijun Liu, Jijia Liu, Feng Li, Wei Li, Haidan Liu · 2023 · Signal Transduction and Targeted Therapy
  97. m6A RNA methylation, a new hallmark in virus-host interactions
    Michèle Brocard, Alessia Ruggieri, Nicolas Locker · 2017 · Journal of General Virology
  98. Perception of self: distinguishing autoimmunity from autoinflammation
    Tessa S. van Kempen, Mark H. Wenink, Emmerik F A Leijten, Timothy R. D. J. Radstake, Marianne L. Boes · 2015 · Nature Reviews Rheumatology
  99. Neo-Antigen mRNA Vaccines
    Arthur Esprit, Wout de Mey, Rajendra Bahadur Shahi, Kris Thielemans, Lorenzo Franceschini, Karine Breckpot · 2020 · Vaccines
  100. The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments
    Janet M. Sasso, Barbara J. B. Ambrose, Rumiana Tenchov, Ruchira S. Datta, Matthew T. Basel, Robert K. DeLong, Qiongqiong Angela Zhou · 2022 · Journal of Medicinal Chemistry